Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.
Anxiety disorders
community mental health services
group psychotherapy
randomized controlled trial
transdiagnostic cognitive-behaviour therapy
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
02 Dec 2020
02 Dec 2020
Historique:
entrez:
2
12
2020
pubmed:
3
12
2020
medline:
3
12
2020
Statut:
aheadofprint
Résumé
Transdiagnostic group cognitive-behavioral therapy (tCBT) is a delivery model that could help overcome barriers to large-scale implementation of evidence-based psychotherapy for anxiety disorders. The aim of this study was to assess the effectiveness of combining group tCBT with treatment-as-usual (TAU), compared to TAU, for the treatment of anxiety disorders in community-based mental health care. In a multicenter single-blind, two-arm pragmatic superiority randomized trial, we recruited participants aged 18-65 who met DSM-5 criteria for principal diagnoses of generalized anxiety disorder, social anxiety disorder, panic disorder, or agoraphobia. Group tCBT consisted of 12 weekly 2 h sessions. There were no restrictions for TAU. The primary outcome measures were the Beck Anxiety Inventory (BAI) and clinician severity rating from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5) for the principal anxiety disorder at post-treatment, with intention-to-treat analysis. A total of 231 participants were randomized to either tCBT + TAU (117) or TAU (114), with outcome data available for, respectively, 95 and 106. Results of the mixed-effects regression models showed superior improvement at post-treatment for participants in tCBT + TAU, compared to TAU, for BAI [p < 0.001; unadjusted post-treatment mean (s.d.): 13.20 (9.13) v. 20.85 (10.96), Cohen's d = 0.76] and ADIS-5 [p < 0.001; 3.27 (2.19) v. 4.93 (2.00), Cohen's d = 0.79]. Our findings suggest that the addition of group tCBT into usual care can reduce symptom severity in patients with anxiety disorders, and support tCBT dissemination in routine community-based care.
Sections du résumé
BACKGROUND
BACKGROUND
Transdiagnostic group cognitive-behavioral therapy (tCBT) is a delivery model that could help overcome barriers to large-scale implementation of evidence-based psychotherapy for anxiety disorders. The aim of this study was to assess the effectiveness of combining group tCBT with treatment-as-usual (TAU), compared to TAU, for the treatment of anxiety disorders in community-based mental health care.
METHODS
METHODS
In a multicenter single-blind, two-arm pragmatic superiority randomized trial, we recruited participants aged 18-65 who met DSM-5 criteria for principal diagnoses of generalized anxiety disorder, social anxiety disorder, panic disorder, or agoraphobia. Group tCBT consisted of 12 weekly 2 h sessions. There were no restrictions for TAU. The primary outcome measures were the Beck Anxiety Inventory (BAI) and clinician severity rating from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5) for the principal anxiety disorder at post-treatment, with intention-to-treat analysis.
RESULTS
RESULTS
A total of 231 participants were randomized to either tCBT + TAU (117) or TAU (114), with outcome data available for, respectively, 95 and 106. Results of the mixed-effects regression models showed superior improvement at post-treatment for participants in tCBT + TAU, compared to TAU, for BAI [p < 0.001; unadjusted post-treatment mean (s.d.): 13.20 (9.13) v. 20.85 (10.96), Cohen's d = 0.76] and ADIS-5 [p < 0.001; 3.27 (2.19) v. 4.93 (2.00), Cohen's d = 0.79].
CONCLUSIONS
CONCLUSIONS
Our findings suggest that the addition of group tCBT into usual care can reduce symptom severity in patients with anxiety disorders, and support tCBT dissemination in routine community-based care.
Identifiants
pubmed: 33261700
doi: 10.1017/S0033291720004316
pii: S0033291720004316
pmc: PMC9647541
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-11Références
Clin Psychol Rev. 2007 Jun;27(5):572-81
pubmed: 17343963
Depress Anxiety. 2012 Sep;29(9):749-53
pubmed: 22949272
J Anxiety Disord. 2017 Mar;46:11-24
pubmed: 27466074
J Clin Psychiatry. 2013 Jun;74(6):595-602
pubmed: 23842011
World Psychiatry. 2016 Oct;15(3):245-258
pubmed: 27717254
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Behav Ther. 2008 Sep;39(3):242-50
pubmed: 18721638
Acta Psychiatr Scand. 2004 Jun;109(6):426-33
pubmed: 15117287
Soc Psychiatry Psychiatr Epidemiol. 2011 Apr;46(4):321-30
pubmed: 20217041
Clin Psychol Rev. 2006 Jan;26(1):17-31
pubmed: 16199119
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Compr Psychiatry. 2014 Nov;55(8):1920-7
pubmed: 25113056
Clin Psychol Rev. 2017 Aug;56:122-137
pubmed: 28450042
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Anxiety Disord. 2009 Oct;23(7):950-7
pubmed: 19586751
Psychotherapy (Chic). 2008 Jun;45(2):214-26
pubmed: 22122418
Stat Med. 1991 Jul;10(7):1123-35
pubmed: 1876800
BMC Psychiatry. 2018 Oct 3;18(1):320
pubmed: 30285672
Psychiatr Serv. 2007 Sep;58(9):1205-11
pubmed: 17766567
Behav Ther. 2012 Sep;43(3):518-32
pubmed: 22697441
J Clin Psychiatry. 2011 Jul;72(7):970-6
pubmed: 21367351
JAMA. 1984 Oct 12;252(14):1905-7
pubmed: 6471323
J Behav Ther Exp Psychiatry. 2005 Jun;36(2):79-97
pubmed: 15814078
Cogn Behav Ther. 2014;43(3):171-84
pubmed: 24646219
J Cogn Psychother. 2014;28(2):117-133
pubmed: 32759111
Depress Anxiety. 2013 Feb;30(2):168-73
pubmed: 23212696
Psychol Med. 2014 Aug;44(11):2363-74
pubmed: 24451993
Behav Res Ther. 2013 Dec;51(12):779-86
pubmed: 24184427
Psychol Med. 2010 Dec;40(12):2059-68
pubmed: 20146834
J Affect Disord. 2015 Apr 1;175:152-67
pubmed: 25618002
Clin Psychol Rev. 2010 Mar;30(2):194-202
pubmed: 19942331
Psychiatr Clin North Am. 2017 Dec;40(4):675-687
pubmed: 29080593
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Behav Ther. 2012 Sep;43(3):506-17
pubmed: 22697440
Depress Anxiety. 2018 Mar;35(3):195-208
pubmed: 29356216
JAMA. 2015 Nov 3;314(17):1818-31
pubmed: 26529160
JAMA Psychiatry. 2017 Sep 1;74(9):875-884
pubmed: 28768327
Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95
pubmed: 8923116
J Nerv Ment Dis. 2007 Jun;195(6):521-31
pubmed: 17568301
Behav Ther. 2016 Nov;47(6):838-853
pubmed: 27993336
Depress Anxiety. 2012 Oct;29(10):874-82
pubmed: 22767410
Lancet. 2017 Dec 17;388(10063):3048-3059
pubmed: 27349358
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Behav Res Ther. 2009 Nov;47(11):902-9
pubmed: 19664756
BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484
BMC Psychiatry. 2014;14 Suppl 1:S1
pubmed: 25081580
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079
BMJ. 2015 May 08;350:h2147
pubmed: 25956159